|
|
Caspian Journal of Internal Medicine، جلد ۱۲، شماره ۱، صفحات ۲۹-۳۴
|
|
|
| عنوان فارسی |
|
|
| چکیده فارسی مقاله |
|
|
| کلیدواژه‌های فارسی مقاله |
|
|
| عنوان انگلیسی |
Analgesic Effect of Duloxetine Compared to Nortryptiline in Patients with painful Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Trial |
|
| چکیده انگلیسی مقاله |
Background: Diabetic neuropathic pain (DNP) is a common complication of diabetes and has a profound effect on patients quality of life. Therefore. The purpose of the present study was to compare the analgesic effects of duloxetine and nortryptiline in the management of patients with diabetic neuropathy. Methods: This was a randomized, double-blind, parallel-group, placebo-controlled trial in subjects with a proven diagnosis of DM and suffered from neuropathic pain. Patients were recruited in this study from 20 February 2016 (first patient, first visit) to 22 June 2017 (last patient, last visit), including 5 weeks follow-up. A diagnosis of DNP was based on history, clinical examination, Nerve conduction velocity and Diabetic neuropathy symptom score (more than one point). Results: Both drugs reduced pain when compared with placebo. A significant VAS reduction from 6.4 at baseline to 3.75 at endpoint was observed in the duloxetine group. However, there was no significant difference in the efficacy between nortriptyline and duloxetine based on patient's visual analogue scale (VAS) (p>0.05). No clinically significant changes or serious adverse events were found among treatment groups including changes in vital signs, laboratory assessments, physical examination or electrocardiograms. The decrease in the mean pain intensity was significantly greater in the duloxetine and nortriptyline group compared to the placebo group both in the primary analysis and in the by-visit analysis (p< 0.003) Conclusions: The present study demonstrates the safety and effectiveness of both duloxetine and nortriptyline in the management of DNP. |
|
| کلیدواژه‌های انگلیسی مقاله |
diabetic peripheral neuropathy, nortriptyline, duloxetine, diabetes, pain |
|
| نویسندگان مقاله |
| Mohammadali Bayani
Department of Internal Medicine, Babol University of Medical sciences, Babol, Iran
| Babak Moazammi
Babol Universtiy of Medical sciences, Babol, Iran
| Farshad Fadaee-Jouybari
Babol Universtiy of Medical sciences, Babol, Iran
| Mansour Babaei
Department of Internal Medicine, Babol University of Medical sciences, Babol, Iran
| Alijan Ahmadi-Ahangar
Mobility Impairment Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran
| Payam Saadat
Mobility Impairment Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran
|
|
| نشانی اینترنتی |
http://caspjim.com/browse.php?a_code=A-10-142-2&slc_lang=en&sid=1 |
| فایل مقاله |
فایلی برای مقاله ذخیره نشده است |
| کد مقاله (doi) |
|
| زبان مقاله منتشر شده |
en |
| موضوعات مقاله منتشر شده |
Endocrinology |
| نوع مقاله منتشر شده |
Original Article |
|
|
|
برگشت به:
صفحه اول پایگاه |
نسخه مرتبط |
نشریه مرتبط |
فهرست نشریات
|